SRA's Top Pharma Stories Of 2015
This article was originally published in SRA
A wide range of issues occupied the minds of regulatory affairs personnel in 2015. According to user stats for Scrip Regulatory Affairs, articles on faster drug review pathways such as the European Medicines Agency's adaptive pathways pilot and new PRIME initiative as well as the EU conditional authorization program drew much attention.
Register for our free email digests: